Non-Invasive Technology for assessment & monitoring of cardiac output

Congestive Heart Failure Impacts Millions of Americans Each Day 5 Million Americans suffer from congestive heart failure 500,000 new patients are diagnosed every year 50% of patients die within 5 years after diagnosis
Congestive Heart Failure Is Treatable and Manageable 
At-Home Monitoring Works 40% reduction in hospitalization rates Monitored patients avg. 9 medication adjustments per year Unmonitored patients avg. only 4 medication adjustments per year
The Problem 1-Existing devices are invasive 2-Existing devices are expensive 3-continuous monitoring Not available The Solution Vital Metrix offers non-invasive, periodic or continuous, cost effective cardiac output measurement in the clinical and home setting.
The Solution

5 issued patents

4 pending patents

Market opportunity Pressure on Hospitals and physicians to reduce hospital readmissions The need to reduce systemic costs as baby boomers age Provide a non-invasive diagnostic option for patients
Scalability Off-the-shelf Sensors Not dependent on one manufacturer Cloud Computing platform 1-runs on amazon’s web service ec2 2-On-demand or reserved access to processors that can rapidly scale without needing to purchase hardware Total Accessible market Home Market-6 Billion Hospitals-5 Billion
Cardiac Output Competitors

Vital Metrix © 2017 All Rights Reserved

Congestive Heart Failure Is Treatable and Manageable 
At-Home Monitoring Works 40% reduction in hospitalization rates Monitored patients avg. 9 medication adjustments per year Unmonitored patients avg. only 4 medication adjustments per year
Congestive Heart Failure Impacts Millions of Americans Each Day 5 Million Americans suffer from congestive heart failure 500,000 new patients are diagnosed every year 50% of patients die within 5 years after diagnosis
The Problem 1-Existing devices are invasive 2-Existing devices are expensive 3-continuous monitoring Not available The Solution Vital Metrix offers non-invasive, periodic or continuous, cost effective cardiac output measurement in the clinical and home setting.
The Solution
Market opportunity Pressure on Hospitals and physicians to reduce hospital readmissions The need to reduce systemic costs as baby boomers age Provide a non-invasive diagnostic option for patients
Scalability Off-the-shelf Sensors Not dependent on one manufacturer Cloud Computing platform 1-runs on amazon’s web service ec2 2-On-demand or reserved access to processors that can rapidly scale without needing to purchase hardware Total Accessible market Home Market-6 Billion Hospitals-5 Billion
Cardiac Output Competitors
Congestive Heart Failure Is Treatable and Manageable 
At-Home Monitoring Works 40% reduction in hospitalization rates Monitored patients avg. 9 medication adjustments per year Unmonitored patients avg. only 4 medication adjustments per year
Congestive Heart Failure Impacts Millions of Americans Each Day 5 Million Americans suffer from congestive heart failure 500,000 new patients are diagnosed every year 50% of patients die within 5 years after diagnosis
The Problem 1-Existing devices are invasive 2-Existing devices are expensive 3-continuous monitoring Not available The Solution Vital Metrix offers non-invasive, periodic or continuous, cost effective cardiac output measurement in the clinical and home setting.
The Solution
Market opportunity Pressure on Hospitals and physicians to reduce hospital readmissions The need to reduce systemic costs as baby boomers age Provide a non-invasive diagnostic option for patients
Scalability Off-the-shelf Sensors Not dependent on one manufacturer Cloud Computing platform 1-runs on amazon’s web service ec2 2-On-demand or reserved access to processors that can rapidly scale without needing to purchase hardware Total Accessible market Home Market-6 Billion Hospitals-5 Billion
Cardiac Output Competitors

TECHNOLOGY

ADVANTAGES

STATUS

MEDIA/NEWS

ABOUT

Congestive Heart Failure Is Treatable and Manageable 
At-Home Monitoring Works 40% reduction in hospitalization rates Monitored patients avg. 9 medication adjustments per year Unmonitored patients avg. only 4 medication adjustments per year
Congestive Heart Failure Impacts Millions of Americans Each Day 5 Million Americans suffer from congestive heart failure 500,000 new patients are diagnosed every year 50% of patients die within 5 years after diagnosis
The Problem 1-Existing devices are invasive 2-Existing devices are expensive 3-continuous monitoring Not available The Solution Vital Metrix offers non-invasive, periodic or continuous, cost effective cardiac output measurement in the clinical and home setting.
The Solution
Market opportunity Pressure on Hospitals and physicians to reduce hospital readmissions The need to reduce systemic costs as baby boomers age Provide a non-invasive diagnostic option for patients
Scalability Off-the-shelf Sensors Not dependent on one manufacturer Cloud Computing platform 1-runs on amazon’s web service ec2 2-On-demand or reserved access to processors that can rapidly scale without needing to purchase hardware Total Accessible market Home Market-6 Billion Hospitals-5 Billion
Cardiac Output Competitors
Congestive Heart Failure Is Treatable and Manageable 
At-Home Monitoring Works 40% reduction in hospitalization rates Monitored patients avg. 9 medication adjustments per year Unmonitored patients avg. only 4 medication adjustments per year
Congestive Heart Failure Impacts Millions of Americans Each Day 5 Million Americans suffer from congestive heart failure 500,000 new patients are diagnosed every year 50% of patients die within 5 years after diagnosis
The Problem 1-Existing devices are invasive 2-Existing devices are expensive 3-continuous monitoring Not available The Solution Vital Metrix offers non-invasive, periodic or continuous, cost effective cardiac output measurement in the clinical and home setting. The Solution
Market opportunity Pressure on Hospitals and physicians to reduce hospital readmissions The need to reduce systemic costs as baby boomers age Provide a non-invasive diagnostic option for patients
Scalability Off-the-shelf Sensors Not dependent on one manufacturer Cloud Computing platform 1-runs on amazon’s web service ec2 2-On-demand or reserved access to processors that can rapidly scale without needing to purchase hardware Total Accessible market Home Market-6 Billion Hospitals-5 Billion
Cardiac Output Competitors